Evidence map›Paper›PMID 36045343›Full record

ArticleBMC biology2022

Combined protein and transcript single-cell RNA sequencing in human peripheral blood mononuclear cells.

Jenifer Vallejo, Ryosuke Saigusa, Rishab Gulati, Sujit Silas Armstrong Suthahar, Vasantika Suryawanshi, Ahmad Alimadadi, Christopher P Durant, Yanal Ghosheh, Payel Roy, Erik Ehinger and 18 more

Erratum issuedAbstract read
In one paragraph

Article in BMC biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Review
  3. CD8Nature reviews. Cardiology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. The protective role of γδ T cells in endometrial cancer.Cancer immunology, immunotherapy : CII · 2025
    Article
  8. Article
  9. Advances in Single-Cell Sequencing for Infectious Diseases: Progress and Perspectives.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. B cells and atherosclerosis: A HIV perspective.Journal of cellular physiology · 2024
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

Jenifer Vallejo *La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA, 92037, USA.
Ryosuke Saigusa *La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA, 92037, USA.
Rishab GulatiLa Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA, 92037, USA.
Sujit Silas Armstrong SuthaharLa Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA, 92037, USA.
Vasantika SuryawanshiLa Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA, 92037, USA.
Ahmad AlimadadiLa Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA, 92037, USA.
Christopher P DurantLa Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA, 92037, USA.
Yanal GhoshehLa Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA, 92037, USA.
Payel RoyLa Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA, 92037, USA.
Erik EhingerLa Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA, 92037, USA.
Tanyaporn PattarabanjirdCarter Immunology Center, Cardiovascular Division, Department of Medicine, University of Virginia, Charlottesville, VA, USA.
David B HannaDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Alan L LandayDepartment of Internal Medicine, Rush University Medical Center, Chicago, IL, USA.
Russell P TracyDepartments of Pathology & Laboratory Medicine and Biochemistry, University of Vermont Larner College of Medicine, Colchester, VT, USA.
Jason M LazarDepartment of Medicine, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
Wendy J MackDepartment of Medicine and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Kathleen M WeberCook County Health/Hektoen Institute of Medicine, Chicago, IL, USA.
Adaora A AdimoraDepartment of Medicine, University of North Carolina School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Howard N HodisDepartment of Medicine and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Phyllis C TienDepartment of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Igho OfotokunDepartment of Medicine, Infectious Disease Division and Grady Health Care System, Emory University School of Medicine, Atlanta, GA, USA.
Sonya L HeathDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Avishai ShemeshParker Institute for Cancer Immunotherapy, University of California, San Francisco, CA, USA.
Coleen A McNamaraCarter Immunology Center, Cardiovascular Division, Department of Medicine, University of Virginia, Charlottesville, VA, USA.
Lewis L LanierParker Institute for Cancer Immunotherapy, University of California, San Francisco, CA, USA.
Catherine C HedrickLa Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA, 92037, USA.
Robert C KaplanDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Klaus LeyLa Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA, 92037, USA. klaus@lji.org.

Funding

Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul A. Goepfert · 1988 to 2026
$84.1M
Engaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
WOMEN'S INTERAGENCY HIV STUDY ORGANIZATION, MANAGEMENT AND COMMUNICATIONSU01AI034989 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AOUIZERAT, BRADLEY E, GREENBLATT, RUTH MARTHA · 1993 to 2018
$65.6M
Women's Interagency HIV Study (WIHS) IIIU01AI031834 · NIAID · SUNY DOWNSTATE MEDICAL CENTER · PI GUSTAFSON, DEBORAH R., MINKOFF, HOWARD · 1998 to 2018
$53.5M
Sex differences in the role of multi-omics in HIV-associated carotid artery atherosclerosisU01HL146204 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI David B. Hanna, Anjali Sharma · 2019 to 2026
$33.2M
Project 4: APOB-specific CD4 and CD8 T cells exacerbate atherosclerosisP01HL136275 · NHLBI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI Catherine C Hedrick · 2017 to 2026
$25.5M
MWCCS: Brooklyn Clinical Research SiteU01HL146202 · NHLBI · SUNY DOWNSTATE MEDICAL CENTER · PI TRACEY ELIZABETH WILSON, Jessica Eve Yager · 2019 to 2026
$23.6M
UNC MACS/WIHS Combined Cohort Study Clinical Research SiteU01HL146194 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Michael Bradley Drummond, Michelle Floris-Moore · 2019 to 2026
$23.2M
Emory WIHS CRS - Longitudinal CohortU01AI103408 · NIAID · EMORY UNIVERSITY · PI OFOTOKUN, IGHOVWERHA, WINGOOD, GINA MARIA · 2013 to 2018
$14.1M
University of North Carolina Womens Interagency HIV Study UNC WIHSU01AI103390 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ADIMORA, ADAORA A · 2013 to 2018
$11.0M
NCATS NIH HHS UL1 TR000004NHLBI NIH HHS K01 HL137557NHLBI NIH HHS P01 HL136275NHLBI NIH HHS R01 HL121697NHLBI NIH HHS R01 HL126543NHLBI NIH HHS R01 HL134236NHLBI NIH HHS R01 HL140976NHLBI NIH HHS R01 HL148094NHLBI NIH HHS R35 HL145241NHLBI NIH HHS U01 HL146194NHLBI NIH HHS U01 HL146202NHLBI NIH HHS U01 HL146204NIAID NIH HHS P30 AI027767NIAID NIH HHS P30 AI050409NIAID NIH HHS U01 AI031834NIAID NIH HHS U01 AI034989NIAID NIH HHS U01 AI103390NIAID NIH HHS U01 AI103408
6 · The paper itself

Abstract

backgroundCryopreserved peripheral blood mononuclear cells (PBMCs) are frequently collected and provide disease- and treatment-relevant data in clinical studies. Here, we developed combined protein (40 antibodies) and transcript single-cell (sc)RNA sequencing (scRNA-seq) in PBMCs.

resultsAmong 31 participants in the Women's Interagency HIV Study (WIHS), we sequenced 41,611 cells. Using Boolean gating followed by Seurat UMAPs (tool for visualizing high-dimensional data) and Louvain clustering, we identified 50 subsets among CD4+ T, CD8+ T, B, NK cells, and monocytes. This resolution was superior to flow cytometry, mass cytometry, or scRNA-seq without antibodies. Combined protein and transcript scRNA-seq allowed for the assessment of disease-related changes in transcriptomes and cell type proportions. As a proof-of-concept, we showed such differences between healthy and matched individuals living with HIV with and without cardiovascular disease.

conclusionsIn conclusion, combined protein and transcript scRNA sequencing is a suitable and powerful method for clinical investigations using PBMCs.

Indexed as

HIV InfectionsLeukocytes, MononuclearFemaleFlow CytometryGene Expression ProfilingHumansSequence Analysis, RNASingle-Cell AnalysisTranscriptomeAntibodiesCVDHIVHumanscRNA-seqTranscriptomes

Identifiers

PMID36045343
PMCPMC9434837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.